Reccan Diagnostics AB

Org no. 556985-4192

Management team

Roland Andersson
CEO & Co-founder

Professor of surgery, Faculty of Medicine at Lund University. He is co-founder of Reccan Diagnostics AB, as well as other biotech companies. Extensive research and clinical experience.

Daniel Ansari 
Scientific Coordinator & Co-founder

Researcher and associate professor (surgery) at Lund University, as well as surgeon at SUS, Skåne University Hospital.  He has extensive research experience in the field of surgery and diagnostics, with special focus on translational research in pancreatic cancer.

György Marko-Varga
Co-founder

Professor and head of the division of clinical protein science and imaging at Lund University, professor at Tokyo Medical University in Japan. He has almost twenty years of experience from Big Pharma, patent applications, novel technological platforms and biobanking.

Board members

Roland Andersson (Chairman)

Professor of surgery, Faculty of Medicine at Lund University. He is co-founder of Reccan Diagnostics AB, as well as other biotech companies. Extensive research and clinical experience.

Christer Fåhraeus 

CEO of EQL Pharma AB and a serial entrepreneur, having founded and developed several successful companies in biotech and engineering. He is Chairman of the board of FlatFrog Laboratories AB, Longboat explorers AB and Respiratorius, as well as board member in CellaVision AB and EQL Pharma AB.

Lars Grundemar

Adjunct Professor of Clinical Pharmacology at Lund University as well as CEO Oncorena and board member of Sinntaxis. Long experience including positions at Pfizer/Pharmacia (USA/Italy), Astra Zeneca and Novartis (Switzerland) and Ferring Pharmaceuticals (Denmark).

Christine Widstrand

Christine Widstrand is Executive Vice President at LU Innovation System AB and responsible for the Life Science portfolio. She holds a PhD in Analytical Chemistry from Lund University. With a background as CEO and founder of several Biotech Companies.

Daniel Ansari

Researcher and associate professor (surgery) at Lund University, as well as surgeon at SUS, Skåne University Hospital.  He has extensive research experience in the field of surgery and diagnostics, with special focus on translational research in pancreatic cancer.

György Marko-Varga

Professor and head of the division of clinical protein science and imaging at Lund University, professor at Tokyo Medical University in Japan. He has almost twenty years of experience from Big Pharma, patent applications, novel technological platforms and biobanking.